RxKinetics Overview

  • Founded
  • 1997
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 21
Employees
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $20M
Latest Deal Amount

RxKinetics General Information

Description

Developer of a drug delivery technologies. The company focuses on developing therapy to treat oral mucositis-mouth sores-in cancer patients.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Delivery
Primary Office
  • Boulder, CO
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

RxKinetics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 12-Oct-2006 $20M 0000 Completed Clinical Trials - Phase 2
1. Early Stage VC 01-Jan-1999 Completed Product Development
To view RxKinetics’s complete valuation and funding history, request access »

RxKinetics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

RxKinetics Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Partisan Management Group Venture Capital Minority 000 0000 000000 0
To view RxKinetics’s complete investors history, request access »